Group A (n = 95) | Group B (n = 60) | P value | |
---|---|---|---|
Female sex | 13 (13.7%) | 13 (21.7%) | 0.195 |
Mean age ± SD, y | 52.08 ± 6.103 | 63.10 ± 3.112 | < 0.01 |
BMI (kg/m2) | 26.12 ± 3.065 | 25.96 ± 2.656 | 0.745 |
Diabetes | 28 (29.5%) | 33 (55.0%) | 0.002 |
Hypertension | 55 (57.9%) | 42 (70.0%) | 0.129 |
Hyperlipidaemia | 64 (67.4%) | 36 (60.0%) | 0.350 |
Previous myocardial infraction | 35 (36.8%) | 19 (31.7%) | 0.510 |
Serum creatinine (μmol/L) | 80.15 ± 13.40 | 82.31 ± 16.83 | 0.379 |
LVEDD (mm) | 42.19 ± 4.879 | 48.88 ± 5.717 | 0.787 |
LVEF (%) | 60.79 ± 5.630 | 60.77 ± 7.249 | 0.983 |
Cardiac function (NYHA) | 0.188 | ||
I | 20 | 9 | – |
II | 65 | 41 | – |
III | 10 | 10 | – |
Peripheral artery stenosis | 15 (15.8%) | 20 (33.3%) | 0.011 |
Preoperative HbA1c(%) | 6.15 ± 0.54 | 6.19 ± 0.51 | 0.673 |